HELP     Sign In
Search

Relevance to Autism

Multiple de novo variants in the ZBTB18 gene, including two de novo loss-of-function (LoF) variants, have been reported in ASD probands (De Rubeis et al., 2014; Feliciano et al., 2019; Wang et al., 2020; Zhou et al., 2022; Trost et al., 2022; More et al., 2023). A case-control mutation burden analysis of 16,000 cases with neurodevelopmental disorders and nonpsychiatric controls from ExAC in Wang et al., 2020 identified ZBTB18 as a gene showing a significant burden of ultra-rare (MAF < 0.01%) gene-disruptive mutations (FDR 5%). Heterozygous mutations in the ZBTB18 gene are responsible for autosomal dominant intellectual developmental disorder-22 (MRD22; OMIM 612337), a disorder characterized by impaired intellectual development with frequent cooccurrence of corpus callosum anomalies, hypotonia, microcephaly, growth problems, and variable facial dysmorphism; stereotypies have been reported in a subset of affected individuals (Lopes et al., 2016; Cohen et al., 2017; Depienne et al., 2017; Trinh et al., 2019).

Molecular Function

This gene encodes a C2H2-type zinc finger protein which acts a transcriptional repressor of genes involved in neuronal development. The encoded protein recognizes a specific sequence motif and recruits components of chromatin to target genes.

External Links

        

References

Type
Title
Type of Disorder
Associated Disorders
Author, Year
Primary
Exome sequencing of 457 autism families recruited online provides evidence for autism risk genes
ASD
Support
Genetic and phenotypic dissection of 1q43q44 microdeletion syndrome and neurodevelopmental phenotypes associated with mutations in ZBTB18 and HNRNPU
Autosomal dominant intellectual developmental diso
Epilepsy/seizures, stereotypy
Support
DD, ID
Autistic features, stereotypy
Support
Autosomal dominant intellectual developmental diso
ADHD, ID, epilepsy/seizures, stereotypy
Support
Identification of novel genetic causes of Rett syndrome-like phenotypes.
Autosomal dominant intellectual developmental diso
Stereotypy
Support
Genomic architecture of autism from comprehensive whole-genome sequence annotation
ASD
Support
Synaptic, transcriptional and chromatin genes disrupted in autism.
ASD
Support
Integrating de novo and inherited variants in 42
ASD
Support
Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders
DD
ASD
Support
ADHD, DD
Epilepsy/seizures
Support
DD, ID
Stereotypy
Support
ASD, DD, ID

Rare

Variant ID
Variant Type
Allele Change
Residue Change
Inheritance Pattern
Inheritance Association
Family Type
Author, Year
 GEN1387R001 
 missense_variant 
 c.1361A>T 
 p.Lys454Met 
 De novo 
  
  
 GEN1387R002 
 synonymous_variant 
 c.1425C>T 
 p.His475= 
 De novo 
  
  
 GEN1387R003 
 stop_gained 
 c.697C>T 
 p.Gln233Ter 
 De novo 
  
  
 GEN1387R004 
 frameshift_variant 
 c.570del 
 p.Asn191ThrfsTer31 
 Unknown 
  
  
 GEN1387R005 
 frameshift_variant 
 c.246dup 
 p.Ala83ArgfsTer7 
 De novo 
  
  
 GEN1387R006 
 frameshift_variant 
 c.658dup 
 p.Thr220AsnfsTer27 
 De novo 
  
  
 GEN1387R007 
 frameshift_variant 
 c.686_687del 
 p.Glu229ValfsTer17 
 De novo 
  
  
 GEN1387R008 
 frameshift_variant 
 c.448del 
 p.Val150SerfsTer11 
 Unknown 
  
  
 GEN1387R009 
 frameshift_variant 
 c.626_627insTCTC 
 p.Glu209AspfsTer39 
 Unknown 
  
  
 GEN1387R010 
 frameshift_variant 
 c.1279_1307dup 
 p.His437LeufsTer36 
 Unknown 
  
  
 GEN1387R011 
 missense_variant 
 c.1414G>A 
 p.Glu472Lys 
 Unknown 
  
  
 GEN1387R012 
 missense_variant 
 c.1444C>T 
 p.Arg482Cys 
 Unknown 
  
  
 GEN1387R013 
 missense_variant 
 c.1483C>T 
 p.Arg495Cys 
 Unknown 
  
  
 GEN1387R014 
 stop_gained 
 c.583C>T 
 p.Arg195Ter 
 De novo 
  
 Simplex 
 GEN1387R015 
 missense_variant 
 c.1517C>T 
 p.Ser506Leu 
 De novo 
  
  
 GEN1387R016 
 missense_variant 
 c.334G>C 
 p.Val112Leu 
 De novo 
  
 Multiplex 
 GEN1387R017 
 stop_gained 
 c.556C>T 
 p.Arg186Ter 
 De novo 
  
 Simplex 
 GEN1387R018 
 missense_variant 
 c.1382A>G 
 p.Asn461Ser 
 De novo 
  
 Simplex 
 GEN1387R019 
 frameshift_variant 
 c.916_917del 
 p.Arg306GlyfsTer4 
 De novo 
  
  
 GEN1387R020 
 stop_gained 
 c.1183C>T 
 p.Gln395Ter 
 De novo 
  
  
 GEN1387R021 
 missense_variant 
 c.1390C>T 
 p.Arg464Cys 
 De novo 
  
 Simplex 
 GEN1387R022 
 stop_gained 
 c.133C>T 
 p.Arg45Ter 
 De novo 
  
 Simplex 
 GEN1387R023 
 missense_variant 
 c.44A>G 
 p.His15Arg 
 De novo 
  
  
 GEN1387R024 
 missense_variant 
 c.1391G>A 
 p.Arg464His 
 De novo 
  
  
 GEN1387R025 
 missense_variant 
 c.1301T>C 
 p.Leu434Pro 
 De novo 
  
  
 GEN1387R026 
 frameshift_variant 
 c.599del 
 p.Ser200Ter 
 De novo 
  
  
 GEN1387R027 
 missense_variant 
 c.1307G>A 
 p.Arg436His 
 De novo 
  
 Simplex 
 GEN1387R028 
 missense_variant 
 c.1306C>T 
 p.Arg436Cys 
 Unknown 
 Not maternal 
  
 GEN1387R029 
 frameshift_variant 
 c.204_205del 
 p.Asp70HisfsTer19 
 De novo 
  
 Simplex 
 GEN1387R030 
 missense_variant 
 c.141C>G 
 p.His47Gln 
 De novo 
  
 Multiplex (monozygotic twins) 
  et al.  
 GEN1387R031 
 missense_variant 
 c.1444C>T 
 p.Arg482Cys 
 De novo 
  
  
  et al.  

Common

No Common Variants Available
Chromosome
CNV Locus
CNV Type
# of studies
Animal Model
1
Duplication
 44
 
1
Duplication
 1
 
1
Duplication
 2
 
1
Duplication
 1
 
1
Deletion
 2
 
1
Deletion
 2
 
1
Duplication
 1
 
1
Duplication
 10
 
1
Deletion-Duplication
 58
 

Model Summary

The transcriptional repressor Zbtb18 is crucial for cell-division patterning and neuronal survival in the developing cortex. Haploinsufficient mutation results in agenesis of the corpus callosum. Behaviorally, the mutants show deficits in the rotarod test, in spontaneous alternation, and in the reversal task in the Morris water maze. Although the mutants show normal high-frequency stimulation (HFS)-induced long term potentiation, they exhibit an earlier saturation after multiple trains of HFS, meaning that the potentiation reaches a lower ceiling than in the mutant in this paradigm.

References

Type
Title
Author, Year

M_ZBTB18_1_KO_HT

Model Type: Genetic
Model Genotype: Heterozygous
Mutation: Exon 1 was replaced with a neo cassette. The absence of protein expression was confirmed by western blot analysis on embryonic brain extracts (MGI:3851929).
Allele Type: Knockout
Strain of Origin: 129/Sv
Genetic Background: C57BL/6J
ES Cell Line: GS1
Mutant ES Cell Line:
Model Source: Haruo Okado lab (PMID 19409883)

M_ZBTB18_1_KO_HT

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
General locomotor activity: ambulatory activity1
Increased
Description: Zbtb18 mutant mice exhibited an increase in locomotion, as measured by total distance traveled, compared to wildtype control mice.
 Open field test
 3 months
Motor coordination and balance1
Decreased
Description: Zbtb18 mutant mice displayed decreased latency to fall in trials 4 and 5 (with no change in trials 1-3) compared to wildtype control mice.
 Accelerating rotarod test
 3 months
Neuroreceptor levels: glutamate receptors: AMPA receptors1
Abnormal
Description: Zbtb18 mutant mice exhibited decreased expression of GluA1, and no change in expression of GluA2, GluA3, or GluA4 subunits compared to wildtype control mice.
 Western blot
 3 months
Dendritic architecture: spine morphology1
Abnormal
Description: Zbtb18 mutant mice exhibited no differences in distribution of spine length and spine width (long thick, short thick, long thin, short thin as a percentage of total spines) of CA1 pyramidal neurons compared to wildtype control mice. However, mutant mice exhibited thinner spine head and shorter spine length in the category of the thick spine (which is defined by spine width as more than 0.6 μm), compared with wildtype controls. In the category of the thin spine (defined by spine width less than 0.6 μm), there were no differences in spine head width and spine length.These results suggest that the characteristics of the matured spines in mutant mice are different from those of wildtype control mice.
Exp Paradigm: Zbtb18 mutant mice crossed with Thy1-GFP transgenic mice
 Confocal microscopy
 6 weeks
Brain morphology1
Abnormal
Description: Zbtb18 mutant mice exhibited agenesis (developmental failure) of the corpus callosum compared to wildtype control mice.
Exp Paradigm: Kluver-Barrera histochemistry
 Histology
 3 months
Neuroreceptor levels: glutamate receptors: NMDA receptors1
Abnormal
Description: Zbtb18 mutant mice exhibited decreased expression of GluN1 and GluN2A subunits, and no change in GluN2B subunits, compared to wildtype control mice.
 Western blot
 3 months
Synaptic transmission: excitatory1
Decreased
Description: Zbtb18 mutant mice exhibited a decrease in the current-voltage (I-V) curve of NMDAR-excitatory postsynaptic currents compared to wildtype controls.
 Whole-cell patch clamp
 3 months
Synaptic plasticity: hippocampal LTP saturation1
Decreased
Description: Zbtb18 mutant mice exhibited early saturation of long-term potentiation compared to wildtype control mice. LTP was saturated via repeated application of tetanic stimulation (100 Hz, 1 s) until no more potentiation was observed.
 Field potential recordings
 3 months
Anxiety1
Increased
Description: Zbtb18 mutant mice exhibited a significant decrease in the amount of time spent in the light compartment compared to wildtype control mice.
 Light-dark exploration test
 3 months
Spatial working memory1
Decreased
Description: Zbtb18 mutant mice exhibited significantly decreased spontaneous alternation rates compared to wildtype control mice.
 Y-maze test
 3 months
Cognitive flexibility1
Decreased
Description: Zbtb18 mutant mice exhibited longer escape latency than compared to wildtype control mice during the reversal test, indicating that mutant mice exhibit an impairment in cognitive memory flexibility.
 Morris water maze test
 3 months
Gene expression1
Decreased
Description: Zbtb18 mutant mice exhibited a decrease in mRNA expression in the cerebral cortex and hippocampus by approximately 40% compared to wildtype controls.
 Quantitative PCR (qRT-PCR)
 P30
Targeted expression1
Decreased
Description: Zbtb18 mutant mice exhibited reduced ZBTB18 levels in the CA1 region of the hippocampus as compared with wildtype control mice.
 Immunohistochemistry
 3 months
Targeted expression1
Decreased
Description: Zbtb18 mutant mice exhibited a decrease in ZBTB18 protein levels in the cerebral cortex compared to wildtype control mice.
 Western blot
 E18
Anxiety1
 No change
 Elevated plus maze test
 3 months
Anxiety1
 No change
 Open field test
 3 months
Cued or contextual fear conditioning: context discrimination1
 No change
 Fear conditioning test
 3 months
Cued or contextual fear conditioning: memory of context1
 No change
 Fear conditioning test
 3 months
Extinction of fear memory1
 No change
 Fear conditioning test
 3 months
Spatial learning1
 No change
 Morris water maze test
 3 months
Spatial reference memory1
 No change
 Morris water maze test
 3 months
Protein expression level evidence1
 No change
 Western blot
 3 months
General locomotor activity1
 No change
 Light-dark exploration test
 3 months
General locomotor activity: ambulatory activity1
 No change
 Y-maze test
 3 months
General locomotor activity: ambulatory activity1
 No change
 Elevated plus maze test
 3 months
Rearing behavior1
 No change
 Open field test
 3 months
Brain morphology1
 No change
 Histology
 3 months
Cortical lamination1
 No change
 Immunohistochemistry
 P0
Dendritic architecture: spine density1
 No change
 Confocal microscopy
 6 weeks
Neurotransporter expression1
 No change
 Western blot
 3 months
Epsp-spike relationship1
 No change
 Field potential recordings
 3 months
Presynaptic function: paired-pulse facilitation1
 No change
 Field potential recordings
 3 months
Synaptic neuroreceptor ratio (NMDAR/AMPAR) dependent transmission1
 No change
 Whole-cell patch clamp
 3 months
Synaptic plasticity: hippocampal LTP1
 No change
 Field potential recordings
 3 months
Synaptic plasticity: post-tetanic potentiation (PTP)1
 No change
 Field potential recordings
 3 months
 Not Reported:

No PIN Data Available
HELP
Copyright © 2017 MindSpec, Inc.